Vincerx Pharma, Inc. to Post Q2 2024 Earnings of ($0.17) Per Share, Leerink Partnrs Forecasts (NASDAQ:VINC)
The Cerbat Gem - 2024-05-19T01:22:42.000Z

Vincerx Pharma, Inc. (NASDAQ:VINC – Free Report) – Stock analysts at Leerink Partnrs raised their Q2 2024 EPS estimates for shares of Vincerx Pharma in a research note issued to investors on Wednesday, May 15th. Leerink Partnrs analyst J. Chang now anticipates that the company will earn ($0.17) per share for the quarter, up from […] Read this story